Key Takeaways

• Drug development moves through structured stages that manage scientific, regulatory, and commercial risk.
• Discovery and early development focus on identifying targets and refining promising compounds.
• Preclinical research tests safety and biological activity before human trials can begin.
• Clinical trials progress through phases to evaluate safety, dosing, and real-world effectiveness.
• Even after approval, post-market monitoring continues to track safety and long-term outcomes.